T1	intervention 0 9	Tamoxifen
T2	control 219 226	placebo
T3	eligibility 230 278	women who are at increased risk of breast cancer
T4	total-participants 284 287	488
T9	outcome 1181 1199	vasomotor symptoms
T11	outcome 971 989	changes in anxiety
T12	outcome 991 995	mood
T13	outcome 1001 1019	sexual functioning
T10	outcome 1262 1272	low energy
T14	outcome 1274 1292	breast sensitivity
T15	outcome 1298 1313	visual blurring
